Nutritional screening and oral supplementation

01Role and principlesWho benefits and the main preventive aims.

Malnutrition means more than low weight. Recent involuntary loss, reduced intake, impaired absorption, inflammation, muscle loss and functional deterioration can occur at any body size. Screening identifies who needs assessment; assessment then considers diagnosis, trajectory, requirements, symptoms, eating environment, capacity and treatment goals.

Oral strategies should be individual rather than ceremonial. Fortifying meals raises energy and protein density without increasing volume; between-meal snacks and prescribed drinks can close a quantified gap. Texture modification, allergy, culture, diabetes, renal disease and fluid restriction change what is suitable, so generic high-calorie advice can be unsafe or ineffective.

Nutrition support requires feedback. A useful prescription states the intended intake and outcome, while review tests whether the patient actually takes it and whether weight, strength, wound healing or treatment tolerance improves. Lack of benefit should trigger diagnosis and delivery review, not automatic accumulation of products.

Key points

Nutritional screening is a repeatable risk-finding process, not a complete dietetic assessment; use a validated tool such as MUST within the setting's agreed timetable.
MUST combines current body mass index, unplanned weight loss and an acute-disease effect when no intake is expected for more than five days.
A high body mass index does not protect against malnutrition: oedema obscures weight, and sarcopenia or micronutrient deficiency can coexist with obesity.
Before prescribing supplements, ask why intake fell: pain, nausea, dysphagia, dental disease, delirium, poverty, restrictive diets, depression, medication and inadequate mealtime assistance are actionable causes.
Use oral nutrition when swallowing is safe and intake can meet goals; enrich ordinary food, offer preferred snacks and add nutritionally complete supplements when food alone is insufficient.
Document an explicit goal, product type, frequency and review date because an unexplained supplement on repeat prescription is not a nutrition plan.
Screen for refeeding risk before substantially increasing energy in a depleted patient; oral drinks and fortified food can precipitate the syndrome just as tube or parenteral feeding can.
Escalate to dietetics and the multidisciplinary nutrition-support team when risk is high, intake remains inadequate, swallowing is unsafe, needs are complex or artificial nutrition is being considered.

02Assessment and patient selectionRisk features, eligibility and important cautions.

Unplanned weight change

Loose clothing, altered rings or dentures, serial records and percentage loss over time may reveal clinically important decline despite a seemingly acceptable current weight.

Reduced intake

Eating less than half of meals, missed meals, early satiety or a prolonged clear-fluid period often precedes biochemical abnormalities and should be quantified.

Functional loss

New difficulty rising, walking, shopping or preparing food can reflect muscle depletion and also perpetuate inadequate access to meals.

Physical signs

Temporal wasting, reduced upper-arm bulk, oedema, poor wound healing, glossitis or pressure injury support concern but are neither sensitive nor cause-specific.

High-risk context

Cancer, chronic lung or gastrointestinal disease, frailty, recent surgery, recurrent admission and social isolation increase risk even before visible wasting appears.

Swallowing barrier

Coughing, wet voice, prolonged meals, pocketing or recurrent chest infection suggests dysphagia and changes the safety of oral supplementation.

Red flags requiring action

A patient with very low intake, major weight loss, low potassium, phosphate or magnesium, or a very low BMI needs immediate refeeding-risk management before unrestricted supplementation.
Choking, inability to handle secretions, recurrent aspiration or acute neurological dysphagia requires urgent swallowing and airway-safety assessment rather than extra oral drinks.
Hypotension, oliguria, confusion or severe electrolyte disturbance indicates acute physiological compromise requiring medical stabilisation alongside nutrition planning.
Progressive dysphagia, persistent vomiting, gastrointestinal bleeding or unexplained weight loss can signal obstruction or malignancy and needs diagnostic escalation.
Refusal of food in a patient with cognitive impairment, severe mental illness or possible neglect demands capacity, safeguarding and multidisciplinary evaluation without coercive assumptions.

03Baseline assessmentMeasurements that guide the plan and track progress.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Validated nutrition screenFirst step
Why
Standardise risk identification and trigger the appropriate local care pathway.
Interpretation and limitations
Calculate each component from reliable measurements and history; oedema, ascites, amputation or an unobtainable height requires documented clinical judgement rather than invented data.
02
Dietary intake assessment
Why
Estimate what is eaten relative to likely energy, protein and fluid requirements.
Interpretation and limitations
A food chart is useful only when portions, supplements and assistance are recorded; a blank tray or untouched bottle can reveal more than a prescribed menu.
03
Weight and anthropometry
Why
Establish trajectory and provide an outcome measure for support.
Interpretation and limitations
Use the same calibrated method where possible and interpret fluid shifts, oedema, ascites and diuresis before labelling change as tissue gain or loss.
04
Clinical and swallowing assessment
Why
Identify symptoms, functional barriers and whether oral intake is safe.
Interpretation and limitations
Speech and language therapy assessment informs consistency and strategies when dysphagia is suspected; dietetics addresses nutritional adequacy within those safety limits.
05
Baseline biochemistry
Why
Detect refeeding vulnerability, dehydration, organ dysfunction and specific suspected deficiencies.
Interpretation and limitations
Urea, electrolytes, magnesium, phosphate, glucose, liver tests and inflammatory context guide safe delivery; albumin is strongly influenced by inflammation and is not a stand-alone nutrition marker.

04InterventionsLifestyle, treatment and escalation options.

01SCREENPositive malnutrition screenFirst stepValidated screening identifies medium or high risk, or clinical concern overrides a low score.

1Confirm weight history, recent intake, acute illness, swallowing safety, symptoms, function and social access to food.
2EscalationAssess refeeding risk and immediate medical instability before recommending rapid nutritional escalation.
3Create a tiered plan with food enrichment, assistance, symptom treatment and dietetic referral proportional to risk.
4EscalationSpecify outcome measures and a review date, then escalate route if oral intake remains unsafe or persistently inadequate.

02ORALFood-first and supplement planSwallowing is safe, the gastrointestinal tract works and oral intake can plausibly meet needs.

1PreferredAgree preferred energy-dense meals, fortification and protein-containing snacks that fit culture, texture and disease constraints.
2Choose a nutritionally complete oral supplement only for a defined gap, with flavour, volume and timing selected to protect appetite for meals.
3Treat nausea, pain, constipation, dry mouth, dental problems and mealtime dependence that undermine adherence.
4Review consumption rather than supply, and stop, switch or intensify the intervention according to weight, function and agreed goals.

03ESCALATEOral strategy is insufficientEscalationIntake remains below need, deterioration continues or oral delivery becomes unsafe.

1Verify that support was available, palatable and taken, and revisit reversible symptoms or environmental barriers.
2Ask speech and language therapy to reassess swallowing where safety or efficiency has changed.
3Discuss enteral feeding when the gut is accessible and functional, or parenteral support when it is not, through the nutrition-support team.
4Align burdens and expected benefits with prognosis, capacity and patient goals rather than treating artificial feeding as an automatic next step.

05Medicines and treatment safetyRegimens, contraindications and review points.

Provide energy, protein and micronutrients when ordinary fortified food cannot close the documented intake gap.

Nutritionally complete oral supplement

Prescribe the product, volume and daily frequency recommended after dietary assessment, usually between meals rather than as an unplanned meal replacement.

Check allergy, texture, renal or fluid restrictions, diabetes, palatability and refeeding risk; record actual consumption and avoid indefinite repeat supply without benefit review.

Reduce thiamine-deficiency complications during the insulin-driven metabolic transition of nutritional rehabilitation.

Thiamine with balanced multivitamin support

Start immediately before and during increased feeding in patients meeting refeeding-risk criteria, following the current local protocol.

Vitamin provision does not replace cautious energy initiation or potassium, phosphate, magnesium and fluid monitoring; use an appropriate route if absorption or oral administration is unreliable.

06Targets, monitoring and follow-upResponse, safety and longer-term review.

Repeat weight at a frequency appropriate to setting and risk, interpreting oedema, ascites, intravenous fluid and diuresis alongside the number.
Measure actual meal and supplement intake, gastrointestinal tolerance and swallowing events instead of assuming delivery because an item was prescribed.
Track function, wound healing, participation in rehabilitation and achievement of the patient's stated goal as well as anthropometry.
For refeeding risk, monitor phosphate, potassium, magnesium, glucose, fluid balance and clinical status at the intensity specified by NICE and local policy.
Review whether symptom treatment, assistance, finances, equipment and discharge supply remain adequate across transitions of care.
Deprescribe unused or no-longer-beneficial supplements and communicate the nutritional indication, duration and review owner to primary care.

07Special situationsVariants, exceptions and circumstances that change the usual approach.

Screening is a doorway

A score opens a structured assessment; it cannot explain the cause, measure muscle directly or decide the route of support by itself.

Inflammation changes interpretation

Low serum albumin often reflects inflammatory redistribution and illness severity, so treating the concentration with calories alone misconstrues the biology.

Consumption beats prescription

A carefully chosen supplement has no effect if nausea, fatigue, packaging difficulty or disliked flavour leaves it unopened at the bedside.

Obesity can conceal depletion

Substantial muscle loss and poor intake may occur at a high BMI; weight-centred visual impressions should not override trajectory and functional evidence.

Goals can be non-weight outcomes

Maintaining independence, tolerating cancer therapy, healing a wound or eating comfortably may be a more meaningful target than a fixed kilogram gain.

08Common pitfallsFrequent interpretation and management errors.

01
Do not use a single albumin result to diagnose malnutrition or judge response, because inflammation and fluid distribution dominate its concentration.
02
Do not add oral supplements before checking swallowing safety, refeeding risk and the practical reason ordinary intake has fallen.
03
Do not exclude malnutrition because a patient is overweight; recent loss and muscle function can reveal serious depletion.
04
Do not prescribe a vague food-first plan without quantities, assistance, accountability and a dated review of achieved intake.
05
Do not let restrictive healthy-eating rules displace energy and protein during acute nutritional rehabilitation unless a specific clinical constraint requires them.
06
Do not continue unwanted supplement flavours on repeat prescription when adherence is poor; adjust formulation, volume, timing or the route itself.